CoChat

Acid sphingomyelinase inhibition suppresses lipopolysaccharide‐mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium‐induced colitis in mice

Open access
Sakata, Akira, Ochiai, Takashi, Shimeno, Hiroshi, Hikishima, Sadao, Yokomatsu, Tsutomu, Shibuya, Shiroshi, Toda, Akihisa, Eyanagi, Reiko, Soeda, Shinji · 2007 · Immunology
Cited by 108

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary: Lipopolysaccharide (LPS) and inflammatory cytokines cause activation of sphingomyelinases (SMases) and subsequent hydrolysis of sphingomyelin (SM) to produce a lipid messenger ceramide. The design of SMase inhibitors may offer new therapies for the treatment of LPS‐ and cytokine‐related inflammatory bowel disease. We synthesized a series of difluoromethylene analogues of SM (SMAs). We report here the effects of the most potent SMase inhibitor, SMA‐7, on the LPS‐mediated release of tumour necrosis factor‐α, interleukin‐1β and interleukin‐6 from THP‐1 macrophages and the pathology of dextran sulphate sodium (DSS)‐induced colitis in mice. SMA‐7 suppressed the LPS‐induced cytokine release and nuclear factor‐κB activation. LPS stimulation caused a four‐fold increase in acid SMase activation, but little increase in neutral SMase activity. The presence of 10 μ m SMA‐7 caused acid SMase to remain at the control levels and reduced the formation of ceramide. HT‐29 cells had significantly decreased cell viability when incubated with media from LPS‐stimulated THP‐1 macrophages. However, incubating the colon cells in media from both SMA‐7 and LPS‐treated macrophages caused little decrease in viability, suggesting that ceramide has a role in the LPS‐stimulated signalling that releases cytotoxic factors against colon cells. Oral administration of SMA‐7 to mice with 2% DSS in the drinking water, for 10 or 21 consecutive days, reduced significantly the cytokine levels in the colon and the severity of colonic injury. These findings suggest a central role for acid SMase/ceramide signalling in the pathology of DSS‐induced colitis in mice, indicating a possible preventive or therapeutic role for SMase inhibitor in inflammatory bowel disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2567.2007.02612.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 108

Metadata

Authors
Sakata, A., Ochiai, T., Shimeno, H., Hikishima, S., Yokomatsu, T., Shibuya, S., Toda, A., Eyanagi, R., & Soeda, S.
Venue
Immunology
Publisher
Wiley
Published
2007-04-23
Volume
122
Issue
1
Pages
54-64
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W2022222076
Cited by
108
References
5
FWCI
2.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acid sphingomyelinase inhibition suppresses lipopolysaccharide‐mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium‐induced colitis in mice. https://app.cochat.ai/papers/10.1111/j.1365-2567.2007.02612.x
The paper
Sakata, A., Ochiai, T., Shimeno, H., Hikishima, S., Yokomatsu, T., Shibuya, S., Toda, A., Eyanagi, R., & Soeda, S. (2007). Acid sphingomyelinase inhibition suppresses lipopolysaccharide‐mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium‐induced colitis in mice. Immunology. https://doi.org/10.1111/j.1365-2567.2007.02612.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.